HLE Glascoat Ltd
Q3 FY24 Earnings Call Analysis
Industrial Manufacturing
fundraise: No informationcapex: Norevenue: Category 3margin: Category 3orderbook: Yes
💰fundraise
Any current/future new fundraising through debt or equity?
- There is no mention of any planned new fundraising through debt or equity in the transcript.
- The company is currently focused on consciously downsizing its debt position, having repaid approximately INR 35 crores already in the first half of the year, with a target to possibly double that by year-end.
- The repayment of debt is being done predominantly through operating and working capital efficiencies.
- No new capex projects are planned for the upcoming year; only replacement capex is expected, indicating limited need for fresh funding.
- Overall, the company appears to prioritize reduced leverage and better cash flows rather than pursuing new fundraising at this time.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- No major capex projects are planned for the upcoming year; focus will be on replacement capex only. (Page 6)
- Recently entered into a joint venture with Clean Max Enviro Private Limited by acquiring a 26% stake in Clean Max Anchorage Private Limited for a total investment up to INR 3.36 crores. (Page 4)
- Clean Max Anchorage Private Limited will develop captive solar and wind power facilities in Gujarat with solar capacity of 2.31 MWp and wind capacity of 3.30 MW. (Page 4)
- The joint venture's project has a short payback period, expected around two years. (Page 10-11)
- No plans currently to venture into the Chinese market or to set up manufacturing facilities there. (Page 7)
📊revenue
Future growth expectations in sales/revenue/volumes?
- Pharma segment revenue is expected to increase over the next few quarters, potentially raising its share from the current lower range (35-60%) closer to the higher end.
- Filtration and drying segment shows a healthy order book with expected execution over 2-3 quarters, indicating a pickup after recent slack.
- The heat transfer equipment segment demonstrated 17% revenue growth, contributing INR 25 crores, expected to continue positive momentum.
- The consolidated order book grew 27% sequentially to INR 602 crores, providing visibility for 5-8 months of revenue.
- New product introductions, especially automations and retrofit packages, aim to enhance customer engagement and drive growth via service and optimization.
- International markets like the US are being penetrated more aggressively, with expectations for faster inroads due to strong service and innovative products.
- The company anticipates sustained or improving margins with operational efficiencies and cross-selling opportunities, notably following Kinam's expansion into new sectors like oil and gas.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- The company expects sustained growth driven by a diversified portfolio and strategic focus, with improved operational efficiencies.
- EBITDA margins in key segments like glass-lined equipment (GLE) are expected to stabilize between 17%-20% long-term.
- Filtration and drying business aims for sustainable margins in the 16%-18% range.
- Profitability and cash flows are expected to improve due to lower interest costs following debt reduction efforts.
- Debt reduction target for FY'25 is around INR 70 crores, enhancing profitability by reducing interest outlay.
- New product launches and service-oriented innovations (like automation and retrofit packages) will enhance customer engagement and drive revenue growth.
- The US market expansion, along with pharma sector traction, is expected to boost order book and revenues.
- Improved working capital and operating cash flows will support steady earnings growth.
- Overall PAT growth of 33% YoY was noted in Q2 FY'25, reflecting positive momentum into future quarters.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- As of September 2024, HLE Glascoat's consolidated order book stands at approximately INR 602 crores, reflecting a sequential growth of 27%.
- The international business order book provides visibility for the next eight months, while the domestic market's order book offers visibility for around five months.
- The filtration, drying, and equipment segments experienced recent order book slack but show renewed momentum, particularly driven by the pharmaceutical sector in southern India.
- Despite some volatility, the company is optimistic about a promising pipeline of opportunities across domestic and international markets in the coming quarters.
